Dual epigenetic targeting with panobinostat and azacitidine in acute myeloid leukemia and high-risk myelodysplastic syndrome.
Tan P, Wei A, Mithraprabhu S, Cummings N, Liu HB, Perugini M, Reed K, Avery S, Patil S, Walker P, Mollee P, Grigg A, D'Andrea R, Dear A, Spencer A.
Tan P, et al. Among authors: walker p.
Blood Cancer J. 2014 Jan 10;4(1):e170. doi: 10.1038/bcj.2013.68.
Blood Cancer J. 2014.
PMID: 24413064
Free PMC article.